Hospira Recalls Diazepam Injection Due to Crystallization Hazard
Hospira Inc. recalls specific lots of Diazepam Injection USP due to crystallized active ingredient particulates. Check lot numbers and expiration dates immediately.
Stop using this now
Crystallization: Product contains particulate identified to be crystallized active ingredient.
Contact the company
What happened, in plain English
Hospira Inc. is recalling specific lots of Diazepam Injection USP 10mg/2mL because the product contains particulate matter identified as crystallized active ingredient. This defect affects 373,850 tubes distributed nationwide. The recall was initiated on June 23, 2016. Read more at govinfonow.com/recall/42576-hospira-recalls-diazepam-injection-due-to-crystallization-hazard.
Source Summary by GovInfoNow · govinfonow.com/recall/42576-hospira-recalls-diazepam-injection-due-to-crystallization-hazard · Updated October 9, 2026 · FDA enforcement record: FDA #D-1359-2016
Cite this page
“Hospira Recalls Diazepam Injection Due to Crystallization Hazard.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42576-hospira-recalls-diazepam-injection-due-to-crystallization-hazard. Based on FDA recall #D-1359-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1359-2016%22&limit=1).
Why it’s dangerous
The presence of crystallized active ingredient particulates means the drug's purity and dosage accuracy may be compromised. Injecting particulate matter can pose serious health risks to the patient, although specific injury details are not provided in this record.
Who’s affected
Patients and healthcare providers who possess or administer the recalled Diazepam Injection USP from the specific lots listed in the record. Individuals with these products are at risk of receiving a compromised medication.
How to tell if you have this one
Check for Diazepam Injection USP 10mg/2mL (5 mg/mL, 2 mL) with NDC 0409-1273-32. Verify if the lot number is 52610LL (Exp. 01 OCT 2016) or 57660LL (Exp. 01 MAR 2017).
- Brand
Hospira- Category
Drug
What to do — step by step
Stop Using Recalled Lots
Do not use any Diazepam Injection from the affected lots due to the risk of crystallized particulates.
Contact Healthcare Provider
Consult your doctor or pharmacist for guidance on replacing the medication if you have one of the recalled lots.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
How many units of this product are being recalled?
A total of 373,850 tubes are included in this recall.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1359-2016 (June 23, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1359-2016 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.